Treatment paradigm and prognostic factor analysis of rectal squamous cell carcinoma- a retrospective study

Author:

Liu Rui1,Zhang Jiahui2

Affiliation:

1. Southwest Medical University

2. The First People's Hospital of Ziyang

Abstract

Abstract Background:Rectal squamous cell carcinoma(rSCC)is a rare pathological type of rectal malignant tumors. There is no consensus on the treatment paradigm of patients with rSCC. This study aims to provide a paradigm for clinical treatment via analyzing the efficacy of different treatment regimens for patients with different TNM stages. Methods:Patients diagnosed with rSCC between 2010 and 2019 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. According to the TNM staging system, Kaplan-Meier(K-M)survival analysis was used to identify the survival benefits of patients with rSCC in different treatment groups. The Cox regression method was used to identify independent prognostic risk factors. Nomograms were evaluated by Harrell's concordance index, calibration curves, DCA and K-M curve. Results:463 patients with rSCC were extracted from the SEER database. Survival analysis showed that there was no significant difference in cancer specific survival (CSS) among radiotherapy(RT), chemoradiotherapy(CRT)and surgeryin Stage 1 (P = 0.249). In TNM Stage 2, there was significant difference in CSS among surgery, RT, and CRT (P = 0.003). In TNM Stage 3, there was significant difference in CSS between CRT, no treatment and CRT plus surgery (P < 0.001). In TNM Stage 4, there was significant difference in CSS between CRT, no treatment and CT (P = 0.041). COX regression analysis showed that Age, Marital status, N, M, CEA, PIN, Size, RT, CT, and surgery were the independent risk factors. The 1-, 3-, and 5-year C-index was 0.869,0.777,0.759, respectively. The calibration curve showed that the model had excellent calibration. The DCA curve showed that the model had excellent clinical application value. Conclusion:RT or surgery is recommended for patients with rSCC at Stage 1, and CRT is recommended for patients with rSCCat Stage 2, Stage 3, and Stage 4. Age, marital status, N, M, PIN, size, RT, CT and surgery are independent risk factors for CSS in patients with rSCC. The prediction model composed of the above independent risk factors has excellent prediction efficiency.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3